Open company graph database — free web & API
Login

Kojin Bio Co., Ltd.

コージンバイオ株式会社
Ticker
Listed market
TYO
Country
Japan
Employees (non-consolidated)
141
Related companies
9
§01

Basic information

BASIC
Head office
5-1-3 Chiyoda, Sakado City, Saitama Prefecture
Chief executive
Takato Nakamura
Capital
12,539,484,400  (125 100 million)
Employees (non-consolidated)
141 people
Employees (consolidated)
Start date
1981-04-20
End date
§02

Websites

1 DOMAINS
§03

Business

5
Sales of medical equipment machineryContracted research animal immunizationManufacture and sale of animal blood and serum, tissue culture media, pharmaceuticals, research antisera, and microbiological testing mediaProduction and sale of experimental animalsBusiness related to import and export
§04

Related companies

9 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Feibo Network Communication Technology Co., Ltd.
Group
Enbio Holdings Inc.
Group
pirm.co.jp
Group Customer
Fresenius Kabi USA
Group
PIRM
Group
米国のCorning Incorporated
Alliance
米国・Corning Incorporated
Alliance
Sysmex Corporation
Shareholder
株式会社Vetanic
Shareholder
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§07

News

38 ARTICLES

KBM Line Check hCG Pregnancy Test LaunchedSources

Kojin Bio Co., Ltd. launched the KBM Line Check hCG pregnancy test on October 1, 2026. The product detects hCG in urine and can provide a result in as little as one minute. It can be used from about one week after the expected start of a period and has an accuracy rate of over 99%.

RepliSkin 3D™ LaunchSources

Cojin Bio has begun manufacturing and selling the tension-enhanced 3D artificial skin model "RepliSkin 3D™." Based on a technology transfer and patent license agreement with OrganTech Inc. regarding artificial skin technology, the company has established a sales system. The impact of the launch on the company's performance is expected to be minimal.

Co-signing a Capital and Business Partnership Agreement with VetanicSources

CoGenBio, together with Sysmex, invested in Vetanic Co., Ltd. and signed a capital and business partnership agreement. The agreement expands the existing business partnership and strengthens a long‑term collaborative framework from a capital perspective. It aims to advance research and development, product commercialization, and future market launch, thereby promoting growth in regenerative medicine and enhancing corporate value. The impact on performance is currently considered minimal.

Exhibition at the 25th Annual Meeting of the Japanese Society for Regenerative MedicineSources

CoGen Bio Inc. has decided to exhibit at the 25th Annual Meeting of the Japanese Society for Regenerative Medicine. The event will take place on March 19-20, 2026, at the Kobe International Conference Center and Kobe International Exhibition Hall, with booth number S-2. Prior registration is required to attend. Additionally, we will exhibit at the ISCT held on March 21.

New Release of 20-Unit Pack of Identification Confirmation Test Tube MediumSources

CoJin Bio Co., Ltd. announced on February 16, 2026, the launch of a 20-unit pack of identification confirmation test tube medium. In addition to the existing 50-unit pack, a small-lot suitable format has been introduced to help reduce expiration and disposal losses. The products covered are the KBM TSI, SIM, SC, LIM, and VP test tube media.

KBM Line Check nCoV/Flu Self-RecallSources

CoGene Bio confirmed that an attached document with a misprinted illustration indicating line appearance during test results was included in some units of the general-use "KBM Line Check nCoV/Flu" product, and has initiated a Class II self-recall. The company apologized to users and pledged to strengthen quality control and prevent recurrence. The impact on performance is expected to be minimal.

Notice Regarding Our Management SystemSources

CoJin Bio apologized to patients, medical institutions, and stakeholders regarding administrative penalties, explaining that deficiencies were pointed out during an on-site inspection concerning compliance with manufacturing and quality management systems. The manufacturing lots used in shipped products and in fatal cases reportedly passed all quality control tests. Investigation into the causes of patients' sudden deterioration and death is ongoing, and at present no causal relationship with the company's products has been confirmed.

Kojin Bio Announces New Antigen Test KitSources

On January 13, 2026, Kojin Bio Co., Ltd. launched KBM Line Check nCoV/Flu II, an antigen test kit for SARS coronavirus and influenza viruses. See the product page for details.

Koji Bio launches new antigen test kit "KBM Line Check nCoV/Flu II"Sources

Koji Bio Co., Ltd. launched a new antigen test kit for SARS coronavirus and influenza virus on January 13, 2026.

Kojin Bio Launches New Hair Follicle and Dermal Mesenchymal Cell Culture KitSources

On December 23, 2025, Kojin Bio Co., Ltd. launched KBM OT002, a kit for culturing hair follicle and dermal mesenchymal cells. See the product page for details. The company appreciates your continued support.

§08

Public records

GOV
National Tax Agency basic information5030001068764
Source: National Tax Agency Corporate Number Publication Site, basic three itemsSources
Trade name
コージンバイオ株式会社
Trade name (kana)
コージンバイオ
Name in English
Corporation type
301
Address
〒350-0214 埼玉県坂戸市千代田5丁目1番地3
Postal code
3500214
Prefecture code
11
City code
239
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date
2015-10-05
Update date
2019-08-16
Change date
2019-08-01
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
令和1年8月1日埼玉県坂戸市千代田五丁目1番地3株式会社ピルム(1030001069568)を合併
Latest record
1
Excluded from search
0
Processing type
71
Correction type
0
Trade name image ID
Address image ID
Sequence number
897839
METI gBizINFO5030001068764
Source: gBizINFO (Ministry of Economy, Trade and Industry)Sources
Corporate number
5030001068764
Trade name
コージンバイオ株式会社
Trade name (kana)
コージンバイオ
Trade name (alphabet)
Registry closure date
Reason for registry closure
Registered address
埼玉県坂戸市千代田5丁目1番地3
Postal code
3500214
Prefecture
埼玉県
Prefecture code
11
City or district
坂戸市
City code
239
Street address
千代田5丁目1番地3
Organisation type
301
Processing type
71
Correction type
0
Status
Representative
代表取締役社長 中村 孝人
Capital
1253984000
Employees
190
Employees (male)
Employees (female)
Business summary
検査用試薬・体外診断薬製造
Website URL
Year founded
Business category
E:製造業
Date established
Unified government qualification - grade
Unified government qualification - business items
Update date
2019-08-16
Key information
5030001068764
§09

Sources & updates

SOURCES
↑